Sandoz to acquire GSK’s cephalosporin antibiotics business for $500m

Sandoz, a division of the Swiss pharmaceutical giant Novartis, has finalized a deal to acquire the cephalosporin antibiotics business from GSK (GlaxoSmithKline) for up to ... Read More